2023
Prevalence of vitamin D deficiency and modifiable risk factors in patients with Crohn's disease: A prospective observational study (Journal article)
Fletcher, J., Brown, M., Hewison, M., Swift, A., & Cooper, S. C. (2023). Prevalence of vitamin D deficiency and modifiable risk factors in patients with Crohn's disease: A prospective observational study. JOURNAL OF ADVANCED NURSING, 79(1), 205-214. doi:10.1111/jan.15476DOI: 10.1111/jan.15476
2021
Protocol for an open-label feasibility study for a randomised controlled trial of vitamin D supplementation in Crohn's Disease patients with vitamin D deficiency: D-CODE Feasiblity study (Journal article)
Fletcher, J., Bedson, E., Brown, M., Hewison, M., Swift, A., & Cooper, S. C. (2021). Protocol for an open-label feasibility study for a randomised controlled trial of vitamin D supplementation in Crohn's Disease patients with vitamin D deficiency: D-CODE Feasiblity study. PILOT AND FEASIBILITY STUDIES, 7(1). doi:10.1186/s40814-021-00813-3DOI: 10.1186/s40814-021-00813-3
Onabotulinum toxin-A versus extended release tolterodine in the management of idiopathic overactive bladder in children: A pilot randomised controlled trial (OVERT trial) (Journal article)
Brown, M., Williamson, P. R., Sutton, L., Melling, C., Lewis, M., J.A.Webb, N., & Goyal, A. (2021). Onabotulinum toxin-A versus extended release tolterodine in the management of idiopathic overactive bladder in children: A pilot randomised controlled trial (OVERT trial). JOURNAL OF PEDIATRIC UROLOGY, 17(1). doi:10.1016/j.jpurol.2020.10.012DOI: 10.1016/j.jpurol.2020.10.012
Hewer, S. C. L., Smyth, A. R., Brown, M., Jones, A. P., Hickey, H., Kenna, D., . . . Williamson, P. R. (2021). Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and <i>Pseudomonas</i> <i>aeruginosa</i> infection: the TORPEDO-CF RCT. HEALTH TECHNOLOGY ASSESSMENT, 25(65), 1-+. doi:10.3310/hta25650DOI: 10.3310/hta25650
2020
Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT (Journal article)
Gilbert, R., Brown, M., Faria, R., Fraser, C., Donohue, C., Rainford, N., . . . Oddie, S. J. (n.d.). Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT. Health Technology Assessment, 24(57), 1-190. doi:10.3310/hta24570DOI: 10.3310/hta24570
Gilbert, R., Brown, M., Faria, R., Fraser, C., Donohue, C., Rainford, N., . . . Oddie, S. J. (2020). Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.. Health technology assessment (Winchester, England), 24(57), 1-190. doi:10.1093/ije/dyw098DOI: 10.1093/ije/dyw098
Hewer, S. C. L., Smyth, A. R., Brown, M., Jones, A. P., Hickey, H., Kenna, D., . . . Grp, T. O. R. P. E. D. O. -C. F. S. (2020). Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial. LANCET RESPIRATORY MEDICINE, 8(10), 975-986. doi:10.1016/S2213-2600(20)30331-3DOI: 10.1016/S2213-2600(20)30331-3
Dorling, J., Tume, L., Arch, B., Woolfall, K., Latten, L., Roper, L., . . . Gale, C. (2020). Gastric residual volume measurement in British neonatal intensive care units: a survey of practice. BMJ PAEDIATRICS OPEN, 4(1). doi:10.1136/bmjpo-2019-000601DOI: 10.1136/bmjpo-2019-000601
Mallucci, C. L., Jenkinson, M. D., Conroy, E. J., Hartley, J. C., Brown, M., Moitt, T., . . . Gamble, C. (2020). Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT. HEALTH TECHNOLOGY ASSESSMENT, 24(17), 1-+. doi:10.3310/hta24170DOI: 10.3310/hta24170
2019
Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation (Journal article)
Mallucci, C. L., Jenkinson, M. D., Conroy, E. J., Hartley, J. C., Brown, M., Dalton, J., . . . Gamble, C. (2019). Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation. Lancet, 394(10208), 1530-1539. doi:10.1016/S0140-6736(19)31603-4DOI: 10.1016/S0140-6736(19)31603-4
Tume, L. N., Arch, B., Woolfall, K., Latten, L., Deja, E., Roper, L., . . . Dorling, J. (2019). Gastric Residual Volume Measurement in UK PICUs: A Survey of Practice*. PEDIATRIC CRITICAL CARE MEDICINE, 20(8), 707-713. doi:10.1097/PCC.0000000000001944DOI: 10.1097/PCC.0000000000001944
Reducing catheter-related bloodstream infections in neonates (Journal article)
Brown, M., Gilbert, R., & Oddie, S. J. (2019). Reducing catheter-related bloodstream infections in neonates. LANCET CHILD & ADOLESCENT HEALTH, 3(8), E12. doi:10.1016/S2352-4642(19)30215-9DOI: 10.1016/S2352-4642(19)30215-9
Gilbert, R., Brown, M., Rainford, N., Donohue, C., Fraser, C., Sinha, A., . . . Team, P. R. E. V. A. I. L. T. (2019). Antimicrobial-impregnated central venous catheters for prevention of neonatal bloodstream infection (PREVAIL): an open-label, parallel-group, pragmatic, randomised controlled trial. Lancet Child and Adolescent Health, 3(6), 381-390. doi:10.1016/S2352-4642(19)30114-2DOI: 10.1016/S2352-4642(19)30114-2
INTRAVENOUS VS ORAL ANTIBIOTICS FOR ERADICATION OF <i>PSEUDOMONAS AERUGINOSA</i> IN CYSTIC FIBROSIS (TORPEDO-CF): A RANDOMISED CONTROLLED TRIAL (Conference Paper)
Smyth, A. R., Hewer, L. S., Brown, M., Jones, A., Hickey, H., Kenna, D., . . . Williamson, P. (2019). INTRAVENOUS VS ORAL ANTIBIOTICS FOR ERADICATION OF <i>PSEUDOMONAS AERUGINOSA</i> IN CYSTIC FIBROSIS (TORPEDO-CF): A RANDOMISED CONTROLLED TRIAL. In PEDIATRIC PULMONOLOGY Vol. 54 (pp. S302). Retrieved from https://www.webofscience.com/
2017
Ridyard, C. H., Plumpton, C. O., Gilbert, R. E., & Hughes, D. A. (2017). Cost-Effectiveness of Pediatric Central Venous Catheters in the UK: A Secondary Publication from the CATCH Clinical Trial. FRONTIERS IN PHARMACOLOGY, 8. doi:10.3389/fphar.2017.00644DOI: 10.3389/fphar.2017.00644
2016
Antibiotic-impregnated catheters for prevention of bloodstream infection reply (Journal article)
Gilbert, R. E., Mok, Q., Millar, M., & Blundell, M. (2016). Antibiotic-impregnated catheters for prevention of bloodstream infection reply. LANCET, 388(10057), 2235-2236. doi:10.1016/S0140-6736(16)31716-0DOI: 10.1016/S0140-6736(16)31716-0
2014
The British antibiotic and silver-impregnated catheters for ventriculoperitoneal shunts multi-centre randomised controlled trial (the BASICS trial): study protocol (Journal article)
Jenkinson, M. D., Gamble, C., Hartley, J. C., Hickey, H., Hughes, D., Blundell, M., . . . Mallucci, C. L. (2014). The British antibiotic and silver-impregnated catheters for ventriculoperitoneal shunts multi-centre randomised controlled trial (the BASICS trial): study protocol. TRIALS, 15. doi:10.1186/1745-6215-15-4DOI: 10.1186/1745-6215-15-4
2013
Vemurafenib for the Treatment of Locally Advanced or Metastatic BRAF V600 Mutation-Positive Malignant Melanoma: A NICE Single Technology Appraisal (Journal article)
Beale, S., Dickson, R., Bagust, A., Blundell, M., Dundar, Y., Boland, A., . . . Proudlove, C. (2013). Vemurafenib for the Treatment of Locally Advanced or Metastatic BRAF V600 Mutation-Positive Malignant Melanoma: A NICE Single Technology Appraisal. PHARMACOECONOMICS, 31(12), 1121-1129. doi:10.1007/s40273-013-0094-xDOI: 10.1007/s40273-013-0094-x
Description of health problem (Journal article)
Brown, T., Pilkington, G., Bagust, A., Boland, A., Oyee, J., Smith, C. T., . . . Dickson, R. (2013). Description of health problem. HEALTH TECHNOLOGY ASSESSMENT, 17(31), 1-+. doi:10.3310/hta17310DOI: 10.3310/hta17310
Rituximab for the First-Line Maintenance Treatment of Follicular Non-Hodgkin’s Lymphoma (Journal article)
Greenhalgh, J., Bagust, A., Boland, A., Blundell, M., Oyee, J., Beale, S., . . . Chu, P. (2013). Rituximab for the First-Line Maintenance Treatment of Follicular Non-Hodgkin’s Lymphoma. PharmacoEconomics, 31(5), 403-413.
Erlotinib in monoterapia nel trattamento di mantenimento del carcinoma polmonare non a piccole cellule dopo chemioterapia a base di platino (Journal article)
Dickson, R., Bagust, A., Boland, A., Blundell, M., Davis, H., Dundar, Y., . . . Ramani, V. S. (2013). Erlotinib in monoterapia nel trattamento di mantenimento del carcinoma polmonare non a piccole cellule dopo chemioterapia a base di platino. PharmacoEconomics Italian Research Articles, 15(1), 35-44. doi:10.1007/s40276-013-0004-4DOI: 10.1007/s40276-013-0004-4
Rituximab for the First-Line Maintenance Treatment of Follicular Non-Hodgkin's Lymphoma A NICE Single Technology Appraisal (Journal article)
Greenhalgh, J., Bagust, A., Boland, A., Blundell, M., Oyee, J., Beale, S., . . . Chu, P. (2013). Rituximab for the First-Line Maintenance Treatment of Follicular Non-Hodgkin's Lymphoma A NICE Single Technology Appraisal. PHARMACOECONOMICS, 31(5), 403-413. doi:10.1007/s40273-013-0043-8DOI: 10.1007/s40273-013-0043-8
2011
Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy A NICE Single Technology Appraisal (Journal article)
Dickson, R., Bagust, A., Boland, A., Blundell, M., Davis, H., Dundar, Y., . . . Ramani, V. S. (2011). Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy A NICE Single Technology Appraisal. PHARMACOECONOMICS, 29(12), 1051-1062. doi:10.2165/11591600-000000000-00000DOI: 10.2165/11591600-000000000-00000
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis (Journal article)
Greenhalgh, J., Bagust, A., Boland, A., Saborido, C. M., Oyee, J., Blundell, M., . . . Fisher, M. (2011). Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis. HEALTH TECHNOLOGY ASSESSMENT, 15(31), 1-+. doi:10.3310/hta15310DOI: 10.3310/hta15310
Comparison of protocols and registry entries to published reports for randomised controlled trials (Journal article)
Dwan, K., Altman, D. G., Cresswell, L., Blundell, M., Gamble, C. L., & Williamson, P. R. (2011). Comparison of protocols and registry entries to published reports for randomised controlled trials. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.MR000031.pub2DOI: 10.1002/14651858.MR000031.pub2
Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy: A NICE Single Technology Appraisal (Journal article)
Dickson, R., Bagust, A., Boland, A., Blundell, M., Davis, H., Dundar, Y., . . . Ramani, V. (2011). Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy: A NICE Single Technology Appraisal. PharmacoEconomics, 29(12), 1051-1062.
Erlotinib monotherapy for the maintenance treatment of non-small cell lung cancer (NSCLC) (Journal article)
Dickson, R., Bagust, A., Boland, A., Blundell, M., Brown, T., Davis, H., . . . Ramani, V. (2011). Erlotinib monotherapy for the maintenance treatment of non-small cell lung cancer (NSCLC). Health Technology Assessment, in pre.
Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis (Journal article)
Fleeman, N., Bagust, A., Boland, A., Dickson, R., Dundar, Y., Moonan, M., . . . Thorp, N. (2011). Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis. HEALTH TECHNOLOGY ASSESSMENT, 15(42), 1-+. doi:10.3310/hta15420DOI: 10.3310/hta15420
Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma: A Single Technology Appraisal (Journal article)
Greenhalgh, J., Bagust, A., Boland, A., Blundell, M., Oyee, J., Dundar, Y., . . . Chu, P. (2011). Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma: A Single Technology Appraisal.
Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma: A Single Technology Appraisal (Journal article)
Greenhalgh, J., Bagust, A., Boland, A., Blundell, M., Oyee, J., Dundar, Y., . . . Chu, P. (2011). Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma: A Single Technology Appraisal.
Ticagrelor for the treatment of acute coronary syndromes: A Single Technology Appraisal (Journal article)
Greenhalgh, J., Bagust, A., Boland, A., Blundell, M., Lai, M., Dundar, Y., . . . Fisher, M. (2011). Ticagrelor for the treatment of acute coronary syndromes: A Single Technology Appraisal.
2010
Comparison of protocols and registry entries to published reports for randomised controlled trials (Conference Paper)
Dwan, K., Altman, D. G., Blundell, M., Gamble, C. L., & Williamson, P. R. (n.d.). Comparison of protocols and registry entries to published reports for randomised controlled trials. In K. Dwan (Ed.). John Wiley & Sons, Ltd. doi:10.1002/14651858.mr000031DOI: 10.1002/14651858.mr000031
Comparison of protocols and registry entries to published reports for randomised controlled trials (Protocol) (Journal article)
Dwan, K., Altman, D. G., Blundell, M., Gamble, C. L., & Williamson, P. R. (2010). Comparison of protocols and registry entries to published reports for randomised controlled trials (Protocol). The Cochrane Library, (10).
